Skip to main content
Top
Published in: Endocrine 3/2014

01-12-2014 | Original Article

Comparative analysis of glucoinsulinemic markers and proinflammatory cytokines in prepubertal children born large-versus appropriate-for gestational age

Authors: Ceren Çetin, Firdevs Baş, Ahmet Uçar, Şükran Poyrazoğlu, Nurçin Saka, Rüveyde Bundak, Feyza Darendeliler

Published in: Endocrine | Issue 3/2014

Login to get access

Abstract

Children born large for gestational age (LGA) may be at risk for development of obesity and insulin resistance (IR). The reciprocal relationship of adipokines and proinflammatory cytokines is suggested to play a putative role in fine tuning of insulin secretory dynamics. To evaluate serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), leptin, insulin-like growth factor-1 (IGF-1), and IGF-binding protein-1 (IGFBP-1) concentrations in idiopathic LGA-born children to appropriate for gestational age (AGA) and idiopathic LGA-born children at prepubertal ages and investigate their associations with IR, evaluated by homeostasis model assessment-IR (HOMA-IR), we conducted a cross-sectional study to compare 40 (19 females) idiopathic LGA-born prepubertal children [mean ± SD age 6.1 ± 2.5 years] and 49 (25 females) (5.4 ± 1.8 years) AGA-born BMI-matched peers with respect to anthropometric and laboratory data. Both groups were further divided into subgroups as being obese/overweight (OW) and non-OW, and the analyses were repeated. LGA-born children were taller and heavier than AGA-born children (p < 0.001). Fasting insulin, HOMA-IR, and leptin were higher in LGA-born children than in AGA-born counterparts (p < 0.001). Serum TNF-α levels were lower and IL-6 levels were significantly higher in LGA- than in AGA-born children (p < 0.001). In the LGA group, TNF-α was correlated with HOMA-IR (r = −0.49, p = 0.002). LGA-born non-OW children had higher serum insulin concentrations and HOMA-IR than AGA-born counterparts. Multivariate regression analysis revealed that HOMA-IR was best explained by (R 2 = 0.517) birth weight SDS (β = +0.418, p = 0.002), leptin (β = +0.620, p = 0.000), and TNF-α (β = −0.374, p = 0.003) in LGA-born children. Idiopathic LGA-born children have significantly lower TNF-α and higher IL-6 levels than AGA-born children. Reduced TNF-α levels are associated with increased IR.
Literature
1.
2.
go back to reference K.K. Ong, C.J. Petry, P.M. Emmett et al., ALSPAC study team. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47, 1064–1070 (2004)PubMed K.K. Ong, C.J. Petry, P.M. Emmett et al., ALSPAC study team. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47, 1064–1070 (2004)PubMed
3.
go back to reference C.M. Boney, A. Verma, R. Tucker et al., Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115, 290–296 (2005)CrossRef C.M. Boney, A. Verma, R. Tucker et al., Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115, 290–296 (2005)CrossRef
4.
go back to reference F. Darendeliler, S. Poyrazoglu, O. Sancakli et al., Adiponectin is an indicator of insulin resistance in non-obese prepubertal children born large for gestational age (LGA) and is affected by birth weight. Clin. Endocrinol. (Oxf). 70, 710–716 (2009)PubMedCrossRef F. Darendeliler, S. Poyrazoglu, O. Sancakli et al., Adiponectin is an indicator of insulin resistance in non-obese prepubertal children born large for gestational age (LGA) and is affected by birth weight. Clin. Endocrinol. (Oxf). 70, 710–716 (2009)PubMedCrossRef
6.
go back to reference D.A. Fields, E.W. Demerath, Relationship of insulin, glucose, leptin, IL-6 and TNF-a in human breast milk with infant growth and body composition. Pediatr. Obes. 7, 304–312 (2012)PubMedCentralPubMedCrossRef D.A. Fields, E.W. Demerath, Relationship of insulin, glucose, leptin, IL-6 and TNF-a in human breast milk with infant growth and body composition. Pediatr. Obes. 7, 304–312 (2012)PubMedCentralPubMedCrossRef
7.
go back to reference G. Amarilyo, A. Oren, F.B. Mimouni, Y. Ochshorn, V. Deutsch, D. Mandel, Increased cord serum inflammatory markers in small-for-gestational-age neonates. J. Perinatol. 31, 30–32 (2011)PubMedCrossRef G. Amarilyo, A. Oren, F.B. Mimouni, Y. Ochshorn, V. Deutsch, D. Mandel, Increased cord serum inflammatory markers in small-for-gestational-age neonates. J. Perinatol. 31, 30–32 (2011)PubMedCrossRef
8.
go back to reference U. Lindner, E. Tutdibi, S. Binot, D. Monz, A. Hilgendorff, L. Gortner, Levels of cytokines in umbilical cord blood in small for gestational age preterm infants. Klin. Padiatr. 225, 70–74 (2013)PubMedCrossRef U. Lindner, E. Tutdibi, S. Binot, D. Monz, A. Hilgendorff, L. Gortner, Levels of cytokines in umbilical cord blood in small for gestational age preterm infants. Klin. Padiatr. 225, 70–74 (2013)PubMedCrossRef
9.
go back to reference McElrath TF., Allred E.N., Van Marter L., Fichorova R.N., Leviton A., for the ELGAN Study Investigators Perinatal systemic inflammatory responses of growth-restricted preterm newborns, Acta Paediatrica 102:e439–e442 (2013) McElrath TF., Allred E.N., Van Marter L., Fichorova R.N., Leviton A., for the ELGAN Study Investigators Perinatal systemic inflammatory responses of growth-restricted preterm newborns, Acta Paediatrica 102:e439–e442 (2013)
10.
go back to reference J.L. Bartha, R. Romero-Carmona, R. Comino-Delgrado, Inflammatory cytokines in intrauterine growth retardation. Acta Obstet. Gynecol. Scand. 82, 1099–1102 (2003)PubMedCrossRef J.L. Bartha, R. Romero-Carmona, R. Comino-Delgrado, Inflammatory cytokines in intrauterine growth retardation. Acta Obstet. Gynecol. Scand. 82, 1099–1102 (2003)PubMedCrossRef
11.
go back to reference M.E. Street, M.A. Ziveri, C. Spaggiari et al., Inflammation is a modulator of the IGF-IGFBP system inducing reduced bioactivity of IGFs in cystic fibrosis. Eur. J. Endocrinol. 154, 1–7 (2006)CrossRef M.E. Street, M.A. Ziveri, C. Spaggiari et al., Inflammation is a modulator of the IGF-IGFBP system inducing reduced bioactivity of IGFs in cystic fibrosis. Eur. J. Endocrinol. 154, 1–7 (2006)CrossRef
12.
go back to reference M.E. Street, C. Volta, M.A. Ziveri et al., Changes and relationships of IGFs and IGFBPs and cytokines in coeliac disease at diagnosis and on gluten-free diet. Clin. Endocrinol. 68, 22–28 (2008)CrossRef M.E. Street, C. Volta, M.A. Ziveri et al., Changes and relationships of IGFs and IGFBPs and cytokines in coeliac disease at diagnosis and on gluten-free diet. Clin. Endocrinol. 68, 22–28 (2008)CrossRef
13.
go back to reference M.E. Street, P. Seghini, S. Fieni et al., Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur. J. Endocrinol. 155, 567–574 (2006)PubMedCrossRef M.E. Street, P. Seghini, S. Fieni et al., Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur. J. Endocrinol. 155, 567–574 (2006)PubMedCrossRef
14.
go back to reference S. Muller, S. Martin, W. Koenig et al., Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute phase proteins but not TNF-alpha or its receptors. Diabetologia 45, 805–812 (2002)PubMedCrossRef S. Muller, S. Martin, W. Koenig et al., Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute phase proteins but not TNF-alpha or its receptors. Diabetologia 45, 805–812 (2002)PubMedCrossRef
15.
go back to reference Y. Miyazaki, R. Pipek, L.J. Mandarino et al., Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 27, 88–94 (2003)PubMedCrossRef Y. Miyazaki, R. Pipek, L.J. Mandarino et al., Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 27, 88–94 (2003)PubMedCrossRef
16.
go back to reference R. Retnakaran, Y. Qi, M. Sermer et al., Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 31, 2026–2031 (2008)PubMedCentralPubMedCrossRef R. Retnakaran, Y. Qi, M. Sermer et al., Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 31, 2026–2031 (2008)PubMedCentralPubMedCrossRef
17.
go back to reference J. Zhang, M. Merialdi, L.D. Platt et al., Defining normal and abnormal fetal growth: promises and challenges. Am. J. Obstet. Gynecol. 202(6), 522–528 (2010)PubMedCentralPubMedCrossRef J. Zhang, M. Merialdi, L.D. Platt et al., Defining normal and abnormal fetal growth: promises and challenges. Am. J. Obstet. Gynecol. 202(6), 522–528 (2010)PubMedCentralPubMedCrossRef
18.
go back to reference J.M. Tanner, Recording adolescent physical changes. Tanner System. Del. Med. J. 45, 84–88 (1973) J.M. Tanner, Recording adolescent physical changes. Tanner System. Del. Med. J. 45, 84–88 (1973)
19.
go back to reference S. Kurtoğlu, N. Hatipoğlu, M.M. Mazıcıoğlu et al., Body weight, length and head circumference at birth a cohort of Turkish newborns. JCRPE 4, 132–139 (2012)PubMedCentralPubMedCrossRef S. Kurtoğlu, N. Hatipoğlu, M.M. Mazıcıoğlu et al., Body weight, length and head circumference at birth a cohort of Turkish newborns. JCRPE 4, 132–139 (2012)PubMedCentralPubMedCrossRef
20.
go back to reference G. Gökçay, A. Furman, O. Neyzi, Updated growth curves for Turkish children aged 15 days to 60 months. Child Care Health Dev. 34, 454–463 (2008)PubMedCrossRef G. Gökçay, A. Furman, O. Neyzi, Updated growth curves for Turkish children aged 15 days to 60 months. Child Care Health Dev. 34, 454–463 (2008)PubMedCrossRef
21.
go back to reference O. Neyzi, A. Furman, R. Bundak et al., Growth references Turkish children aged 6 to 18 years. Acta. Paediatr. 95, 1635–1641 (2006)PubMedCrossRef O. Neyzi, A. Furman, R. Bundak et al., Growth references Turkish children aged 6 to 18 years. Acta. Paediatr. 95, 1635–1641 (2006)PubMedCrossRef
22.
go back to reference R. Bundak, A. Furman, H. Gunoz et al., Body mass index references for Turkish children. Acta Paediatr. 95, 194–198 (2006)PubMedCrossRef R. Bundak, A. Furman, H. Gunoz et al., Body mass index references for Turkish children. Acta Paediatr. 95, 194–198 (2006)PubMedCrossRef
23.
go back to reference N. Hatipoğlu, A. Öztürk, M.M. Mazicioğlu et al., Waist circumference percentiles for 7-to 17-years-old Turkish children and adolescents. Eur. J. Pediatr. 167, 383–389 (2008)PubMedCrossRef N. Hatipoğlu, A. Öztürk, M.M. Mazicioğlu et al., Waist circumference percentiles for 7-to 17-years-old Turkish children and adolescents. Eur. J. Pediatr. 167, 383–389 (2008)PubMedCrossRef
25.
go back to reference R.P. Troiano, K.M. Flegal, R.J. Kuczmarski et al., Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch. Pediatr. Adolesc. Med. 149, 1085–1091 (1995)PubMedCrossRef R.P. Troiano, K.M. Flegal, R.J. Kuczmarski et al., Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch. Pediatr. Adolesc. Med. 149, 1085–1091 (1995)PubMedCrossRef
26.
go back to reference T.J. Cole, M.C. Bellizzi, K.M. Flegal et al., Establishing a standard definition for child overweight and obesity worldwide: international survey. Br. Med. J. 320, 1240–1243 (2000)CrossRef T.J. Cole, M.C. Bellizzi, K.M. Flegal et al., Establishing a standard definition for child overweight and obesity worldwide: international survey. Br. Med. J. 320, 1240–1243 (2000)CrossRef
27.
go back to reference D.R. Matthews, J.P. Hosker, A.S. Rudenski et al., Homeostasis model assessment: insulin resistance and & #x03B2;-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)PubMedCrossRef D.R. Matthews, J.P. Hosker, A.S. Rudenski et al., Homeostasis model assessment: insulin resistance and & #x03B2;-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)PubMedCrossRef
28.
go back to reference V. Giapros, E. Evagelidou, A. Challa et al., Serum adiponectin and leptin levels and insulin resistance in children born large for gestational age are affected by the degree of overweight. Clin. Endocrinol. 66, 353–359 (2007)CrossRef V. Giapros, E. Evagelidou, A. Challa et al., Serum adiponectin and leptin levels and insulin resistance in children born large for gestational age are affected by the degree of overweight. Clin. Endocrinol. 66, 353–359 (2007)CrossRef
29.
go back to reference J.S. Dyer, C.R. Rosenfeld, J. Rice et al., Insulin resistance in Hispanic large-for-gestational-age neonates at birth. J. Clin. Endocrinol. Metab. 92, 3836–3843 (2007)PubMedCrossRef J.S. Dyer, C.R. Rosenfeld, J. Rice et al., Insulin resistance in Hispanic large-for-gestational-age neonates at birth. J. Clin. Endocrinol. Metab. 92, 3836–3843 (2007)PubMedCrossRef
30.
go back to reference A.S. Challa, E.N. Evagelidou, V.I. Giapros et al., Growth factors, adiponectin, leptin and body mass index in pre-pubertal children born large for gestational age. J. Endocrinol. Invest. 34, 411–416 (2011)PubMedCrossRef A.S. Challa, E.N. Evagelidou, V.I. Giapros et al., Growth factors, adiponectin, leptin and body mass index in pre-pubertal children born large for gestational age. J. Endocrinol. Invest. 34, 411–416 (2011)PubMedCrossRef
31.
go back to reference M.S. Sandhu, A.H. Heald, J.M. Gibson et al., Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359, 1740–1745 (2002)PubMedCrossRef M.S. Sandhu, A.H. Heald, J.M. Gibson et al., Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359, 1740–1745 (2002)PubMedCrossRef
32.
go back to reference Y. Miyazaki, R. Pipek, L.J. Mandarino et al., Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 27, 88–94 (2003)PubMedCrossRef Y. Miyazaki, R. Pipek, L.J. Mandarino et al., Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 27, 88–94 (2003)PubMedCrossRef
33.
go back to reference H.S. Park, J.Y. Park, R. Yu, Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract. 69(1), 29–35 (2005)PubMedCrossRef H.S. Park, J.Y. Park, R. Yu, Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract. 69(1), 29–35 (2005)PubMedCrossRef
34.
go back to reference E.H. Choy, D.A. Isenberg, T. Garrood et al., Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis. Rheum. 46, 3143–3150 (2002)PubMedCrossRef E.H. Choy, D.A. Isenberg, T. Garrood et al., Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis. Rheum. 46, 3143–3150 (2002)PubMedCrossRef
35.
go back to reference A.M. Petersen, B.K. Pedersen, The anti-inflammatory effect of exercise. J. Appl. Physiol. 98, 1154–1162 (2005)PubMedCrossRef A.M. Petersen, B.K. Pedersen, The anti-inflammatory effect of exercise. J. Appl. Physiol. 98, 1154–1162 (2005)PubMedCrossRef
36.
go back to reference R. Starkie, S.R. Ostrowski, S. Jauffred et al., Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 17, 884–886 (2003)PubMed R. Starkie, S.R. Ostrowski, S. Jauffred et al., Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 17, 884–886 (2003)PubMed
37.
go back to reference C. Jefferies, P. Hofman, J. Keelan et al., Insulin resistance is not due to persistently elevated serum tumour necrosis-α levels in small for gestational age, premature or twin children. Pediatr. Diabetes 5, 20–25 (2004)PubMedCrossRef C. Jefferies, P. Hofman, J. Keelan et al., Insulin resistance is not due to persistently elevated serum tumour necrosis-α levels in small for gestational age, premature or twin children. Pediatr. Diabetes 5, 20–25 (2004)PubMedCrossRef
38.
go back to reference D.A. Joyce, J.H. Steer, L.J. Abraham, Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm. Res. 46, 447–451 (1997)PubMedCrossRef D.A. Joyce, J.H. Steer, L.J. Abraham, Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm. Res. 46, 447–451 (1997)PubMedCrossRef
39.
go back to reference S.L. Bakker, R.O.B. Gans, J.C. Ter Maaten et al., The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis 155, 283–290 (2001)PubMedCrossRef S.L. Bakker, R.O.B. Gans, J.C. Ter Maaten et al., The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis 155, 283–290 (2001)PubMedCrossRef
40.
go back to reference M.W. Chong, H.E. Thomas, T.W.H. Kay, Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumour necrosis factor. J. Biol. Chem. 277, 27945–27952 (2002)PubMedCrossRef M.W. Chong, H.E. Thomas, T.W.H. Kay, Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumour necrosis factor. J. Biol. Chem. 277, 27945–27952 (2002)PubMedCrossRef
41.
go back to reference L.P. Palaniappan, M.R. Carnethon, S.P. Fortmann, Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin. Diabetes Care 25, 1351–1357 (2002)PubMedCentralPubMedCrossRef L.P. Palaniappan, M.R. Carnethon, S.P. Fortmann, Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin. Diabetes Care 25, 1351–1357 (2002)PubMedCentralPubMedCrossRef
42.
go back to reference D. McCarthy, Body fat measurements in children as predictors for the metabolic syndrome: focus on waist circumference. Proc. Nutr. Soc. 65, 385–392 (2006)PubMed D. McCarthy, Body fat measurements in children as predictors for the metabolic syndrome: focus on waist circumference. Proc. Nutr. Soc. 65, 385–392 (2006)PubMed
43.
go back to reference C. Levy-Marchal, S. Arslanian, W. Cutfield, et al. and on behalf of ESPE-LWPES-ISPAD-APPES-APEG-SLEP-JSPE, and the Insulin Resistance in Children Consensus Conference Group Insulin. Resistance in Children: consensus, perspective, and future directions. J. Clin. Endocrinol. Metab. 95(12):5189–5198 (2010) C. Levy-Marchal, S. Arslanian, W. Cutfield, et al. and on behalf of ESPE-LWPES-ISPAD-APPES-APEG-SLEP-JSPE, and the Insulin Resistance in Children Consensus Conference Group Insulin. Resistance in Children: consensus, perspective, and future directions. J. Clin. Endocrinol. Metab. 95(12):5189–5198 (2010)
Metadata
Title
Comparative analysis of glucoinsulinemic markers and proinflammatory cytokines in prepubertal children born large-versus appropriate-for gestational age
Authors
Ceren Çetin
Firdevs Baş
Ahmet Uçar
Şükran Poyrazoğlu
Nurçin Saka
Rüveyde Bundak
Feyza Darendeliler
Publication date
01-12-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0207-0

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.